Century Therapeutics, Inc.
IPSC
$1.92
-$0.01-0.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -109.79M | -107.79M | -9.58M | -26.48M | -23.28M |
| Total Depreciation and Amortization | 12.30M | 12.88M | 13.10M | 12.87M | 13.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.14M | 5.18M | 7.16M | 17.47M | 13.33M |
| Change in Net Operating Assets | -3.40M | -4.79M | -114.55M | -115.88M | -117.86M |
| Cash from Operations | -86.76M | -94.52M | -103.88M | -112.02M | -114.77M |
| Capital Expenditure | -1.33M | -957.00K | -848.00K | -1.14M | -142.00K |
| Sale of Property, Plant, and Equipment | 59.00K | -- | -- | -21.00K | 0.00 |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.54M | -32.09M | 108.35M | 116.91M | 130.42M |
| Cash from Investing | -47.82M | -33.04M | 107.50M | 115.75M | 130.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 126.99M | 126.68M | 173.00K | 120.00K | 393.00K |
| Repurchase of Common Stock | -- | -- | -- | -602.00K | -602.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 126.99M | 126.68M | 173.00K | -482.00K | -209.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.59M | -883.00K | 3.80M | 3.24M | 15.30M |